Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1397 - mpMRI prostate diagnostic scans

The documents on this page may not be accessible, should you require assistance accessing the information please contact the MSAC Secretariat

Comment on the Consultation Protocol closed at 11:59pm on 17 July 2015

Application Number1397
Application NamempMRI prostate diagnostic scans
Description of Medical ServiceThe radiological procedure of multiparametric MRI of the prostate. This consists of a standardized image acquisition protocol involving T2 weighted imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement. It is interpreted using a standardized reporting system, the most common of which is PIRADS.
Description of Medical ConditionIn patients with a raised or concerning PSA and under clinical suspicion for prostate cancer, sent by the GP to a specialist Urologist, imaging the prostate with mpMRI before biopsy has major patient benefits, increases patient QALY’s, and is cheaper than the current diagnostic pathway. The number of men that need any biopsy at all by about 50%.The number of men diagnosed with low risk cancer reduces by about 90%, preventing overtreatment and the MRI and targeted biopsy pathway is more accurate than random TRUS biopsies and also gives a better grading of the patient’s particular tumour and uses 90% less needles.
Consultation ProtocolConsultation Protocol (PDF 188 KB)
Consultation Protocol (Word 590 KB)

Feedback and Survey Form (PDF 35 KB)
Feedback and Survey Form (Word 107 KB)
Final ProtocolFinal Protocol (PDF 1672 KB)
Final Protocol (Word 347 KB)
Reports-
MSAC Outcomes-

Meetings for this Application

Meeting Type:Date:
PASC16 April 2015
13-14 August 2015
ESC -
MSAC -

Page currency, Latest update: 18 March, 2016